Puech F, Gosselin G, Balzarini J, Good S S, Rideout J L, De Clercq E, Imbach J L
Laboratoire de Chimie Bio-organique, Université des Sciences et Techniques du Languedoc, Montpellier, France.
Antiviral Res. 1990 Jul;14(1):11-23. doi: 10.1016/0166-3542(90)90062-c.
The 5'----5' dinucleoside methylphosphonates of 3'-azido-3'-deoxythymidine (AZT) and 2',3'-dideoxycytidine (DDC) were prepared and evaluated for their inhibitory properties against different viruses, including human immunodeficiency virus (HIV). The synthesis of the compounds was achieved by reaction of AZT or N4-(4-monomethoxytrityl)-2',3'-dideoxycytidine with in situ prepared methylphosphonic bis (triazolide), followed in the latter case by an acidic treatment. The two title compounds showed in vitro anti-HIV activity, that was 200- to 450-fold less pronounced that that shown by the corresponding monomeric nucleosides AZT and DDC. The decreased antiviral activity may be ascribed to nuclease resistance of the methylphosphonate linkage.
制备了3'-叠氮基-3'-脱氧胸苷(AZT)和2',3'-双脱氧胞苷(DDC)的5'- - -5'二核苷甲基膦酸酯,并评估了它们对包括人类免疫缺陷病毒(HIV)在内的不同病毒的抑制特性。这些化合物的合成是通过AZT或N4-(4-单甲氧基三苯甲基)-2',3'-双脱氧胞苷与原位制备的甲基膦酸双(三唑化物)反应实现的,后一种情况接着进行酸性处理。这两种标题化合物表现出体外抗HIV活性,但其活性比相应的单体核苷AZT和DDC低200至450倍。抗病毒活性的降低可能归因于甲基膦酸酯键对核酸酶的抗性。